PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY
<p><strong>Objective: </strong>to study the prognostic value of alterations in the VHL gene and the plasma markers hVEGF, hVEGFR2, and hVEGFR3 in patients with metastatic kidney cancer (KC) who receive targeted therapy.</p><p><strong>Subjects and methods. </str...
Main Authors: | M. V. Peters, V. E. Shevchenko, V. B. Matveev, M. I. Volkova, S. A. Kalinin, D. M. Mikhailenko, D. V. Zaletayev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | http://oncourology.abvpress.ru/index.php/oncur/article/view/185 |
Similar Items
-
PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY
by: M. V. Peters, et al.
Published: (2014-07-01) -
PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01) -
PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01) -
Molecular features of renal cell carcinoma: early diagnostics and perspectives for therapy
by: O. V. Kovaleva, et al.
Published: (2015-06-01) -
PROGNOSTIC SIGNIFICANCE OF KI-67, MMP-9 AND COL IV IMMUNOHISTOCHEMICAL MARKERS AT BLADDER TUMORS
by: V. P. Avdoshin, et al.
Published: (2014-08-01)